Northern Trust
COYA icon

Northern Trust’s Coya Therapeutics COYA Stock Holding History

Northern Trust’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Buy
45,072
+4,654
+12% +$21.6K ﹤0.01% 3851
2026
Q1 		$159K Hold
40,418
– – ﹤0.01% 4004
2025
Q4 		$234K Buy
40,418
+8,097
+25% +$49.2K ﹤0.01% 3922
2025
Q3 		$184K Sell
32,321
-7,055
-18% -$42.9K ﹤0.01% 4008
2025
Q2 		$226K Buy
39,376
+8,197
+26% +$47.5K ﹤0.01% 3896
2025
Q1 		$202K Buy
31,179
+2,630
+9% +$16.7K ﹤0.01% 3942
2024
Q4 		$164K Buy
28,549
+3,099
+12% +$21.1K ﹤0.01% 4044
2024
Q3 		$164K Hold
25,450
– – ﹤0.01% 3942
2024
Q2 		$154K Sell
25,450
-17
-0.1% -$137 ﹤0.01% 3941
2024
Q1 		$253K Buy
25,467
+10,594
+71% +$83K ﹤0.01% 3813
2023
Q4 		$110K Buy
+14,873
New +$82.5K ﹤0.01% 4092

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Northern Trust's COYA Position: Q2 2026 in Review

Northern Trust increased its Coya Therapeutics (COYA) stake by 12% in Q2 2026, buying an estimated $21.6K and bringing the position to 45,072 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #3851.

Northern Trust first reported a position in COYA in Q4 2023 and has held it in 11 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Northern Trust held 45,072 shares of Coya Therapeutics worth $264K as of Q2 2026.
  • Northern Trust bought 4,654 Coya Therapeutics shares in Q2 2026, an estimated $21.6K.
  • Coya Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3851 holding.
  • Northern Trust first reported a position in Coya Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.